Is There a Generic for Rezdiffra? A Look at Resmetirom's Patent and Future Availability
•
4 min read
In March 2024, Rezdiffra (resmetirom) became the first FDA-approved medication specifically for noncirrhotic non-alcoholic steatohepatitis (NASH), now known as MASH. This landmark approval was a significant development for patients and healthcare providers, yet it has raised a critical question: is there a generic for Rezdiffra? The short answer is no, and its status as a brand-name-only medication is tied to complex legal and commercial factors.
